Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo
- PMID: 24269076
- PMCID: PMC3859721
- DOI: 10.1016/j.metabol.2013.09.018
Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo
Abstract
Objective: Patients with gout have lower calcitriol levels that improve when uric acid is lowered. The mechanism of these observations is unknown. We hypothesized that uric acid inhibits 1-αhydroxylase.
Materials and methods: In vivo, Sprague Dawley rats were randomized to control (n = 5), allantoxanamide (n=8), febuxostat (n=5), or allantoxanamide+febuxostat (n = 7). Vitamin D, PTH, and 1-αhydroxylase protein were evaluated. In order to directly evaluate the effect of uric acid on 1-αhydroxylase, we conducted a series of dose response and time course experiments in vitro. Nuclear factor κ-B (NFκB) was inhibited pharmacologically. Finally, to evaluate the potential implications of these findings in humans, the association between uric acid and PTH in humans was evaluated in a cross-sectional analysis of data from the NHANES (2003-2006); n = 9773.
Results: 1,25(OH)2D and 1-αhydroxylase protein were reduced in hyperuricemic rats and improved with febuxostat treatment. Uric acid suppressed 1-αhydroxylase protein and mRNA expression in proximal tubular cells. This was prevented by NFκB inhibition. In humans, for every 1mg/dL increase in uric acid, the adjusted odds ratio for an elevated PTH (>65 pg/mL) was 1.21 (95% C.I. 1.14, 1.28; P<0.0001), 1.15 (95% C.I. 1.08, 1.22; P<0.0001), and 1.16 (95% C.I. 1.03, 1.31; P = 0.02) for all subjects, subjects with estimated GFR ≥ 60, and subjects with estimated GFR <60 mL/min/1.73 m(2) respectively.
Conclusion: Hyperuricemia suppresses 1-αhydroxylase leading to lower 1,25(OH)2D and higher PTH in rats. Our results suggest this is mediated by NFκB. The association between uric acid and PTH in NHANES suggests potential implications for human disease.
Keywords: 1,25 dihydroxy-vitamin D; 1,25(OH)(2)D; 25 hydroxyvitamin D; 25(OH)D; ATX; BMI; CKD; FBXT; GFR; IQR; MBD; MDRD; Mineral and bone disorder; Mineral and bone disorders; Modification of Diet in Renal Disease; NFκB; NHANES; National Health and Nutrition Examination Survey; PTH; Parathyroid hormone; Uric acid; allantoxanamide; body mass index; chronic kidney disease; febuxostat; glomerular filtration rate; inter-quartile range; nuclear factor κ- B; parathyroid hormone.
© 2013.
Figures
Similar articles
-
The role of insulin in the stimulation of renal 1,25-dihydroxyvitamin D synthesis by parathyroid hormone in rats.Endocrinology. 1987 Nov;121(5):1721-6. doi: 10.1210/endo-121-5-1721. Endocrinology. 1987. PMID: 3311717
-
25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.Kidney Int. 2006 Aug;70(4):654-9. doi: 10.1038/sj.ki.5000394. Kidney Int. 2006. PMID: 16807549
-
Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.Bone. 2009 Apr;44(4):678-83. doi: 10.1016/j.bone.2008.11.016. Epub 2008 Dec 9. Bone. 2009. PMID: 19111635
-
Main endocrine modulators of vitamin D hydroxylases in human pathophysiology.J Steroid Biochem. 1987;27(4-6):815-24. doi: 10.1016/0022-4731(87)90154-3. J Steroid Biochem. 1987. PMID: 3320561 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
High Prevalence and Risk Factors Associated with Vitamin D Deficiency Among Chinese Hospital Staff: A Cross-Sectional Study.Int J Gen Med. 2024 May 3;17:1833-1843. doi: 10.2147/IJGM.S453473. eCollection 2024. Int J Gen Med. 2024. PMID: 38715746 Free PMC article.
-
Pathophysiology and Treatment of Gout Arthritis; including Gout Arthritis of Hip Joint: A Literature Review.Hip Pelvis. 2024 Mar 1;36(1):1-11. doi: 10.5371/hp.2024.36.1.1. Hip Pelvis. 2024. PMID: 38420734 Free PMC article. Review.
-
Uncovering the Potential Mechanisms and Effects of Hyperuricemia and its Associated Diseases on Male Reproduction.Reprod Sci. 2024 Feb 20. doi: 10.1007/s43032-024-01453-7. Online ahead of print. Reprod Sci. 2024. PMID: 38379071 Review.
-
Genotype and Phenotype of Renal Hypouricemia: A Single-Center Study from China.Mol Diagn Ther. 2024 Jan;28(1):87-99. doi: 10.1007/s40291-023-00683-w. Epub 2023 Nov 16. Mol Diagn Ther. 2024. PMID: 37971623
-
Relationship between serum uric acid levels and osteoporosis.Endocr Connect. 2023 Oct 13;12(11):e230040. doi: 10.1530/EC-23-0040. Print 2023 Nov 1. Endocr Connect. 2023. PMID: 37855329 Free PMC article. Review.
References
-
- Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72(3):247–59. - PubMed
-
- Brantsma AH, Bakker SJ, Hillege HL, et al. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant. 2008;23(12):3851–8. - PubMed
-
- Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305. - PubMed
-
- McCullough PA, Jurkovitz CT, Pergola PE, et al. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP) Arch Intern Med. 2007;167(11):1122–9. - PubMed
-
- McCullough PA, Li S, Jurkovitz CT, et al. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J. 2008;156(2):277–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous